Singapore - TAKEN 3 holds onto the no. 1 spot for a second weekend. It's still playing on 56 screens, which is more than INTO THE WOODS (PG13), the highest debut at no. 2 with 41 screens.
Apart from the musical WOODS, four other new films start in the top ten: BLACKHAT (NC16 / 37 screens) at no. 3; BIRDMAN (M18 / 16 screens) at no. 4; THE WOMAN IN BLACK: ANGEL OF DEATH (PG13 / 21 screens) at no. 5 and PARASYTE PART 1 (NC16 / 11 screens) at no. 7.
The edited NC16 cut of WHIPLASH (7 screens) and the single screen showcase BHOPAL: A PRAYER FOR RAIN (PG) start outside the top ten.
Note: Number for screens is an estimate based on information gathered from exhibitors' websites.
UPDATE:
Box Office Mojo, which went without updates from 16 Nov 2014 has started to publish the missing weeks. Rather than to do a revised update, I thought I'll just add an appendix to compare how accurately I counted the number of screens. For movies opening on lots of screens (usually multiple prints at single locations), I tend to get the numbers wrong. For releases in the teens or single digits, the discrepancy (if any) is minute.
Box Office (15-18 Jan)
1 (1) Taken 3 (PG13)
US$561,490 / US$2,375,326
57 screens
2 (-) Into the Woods (PG13)
US$404,540 / US$429,591
34 screens
3 (-) Blackhat (NC16)
US$234,993 / US$249,545
32 screens
4 (-) Birdman (M18)
US$108,585 / US$115,309
16 screens
US$108,585 / US$115,309
16 screens
5 (-) The Woman in Black: Angel of Death (PG13)
US$101,744 / US$108,044
20 screens
US$101,744 / US$108,044
20 screens
US$96,737 / US$271,737
15 screens
7 (-) Parasite: Part 1 (NC16)
US$57,161 / US$60,700
11 screens
US$57,161 / US$60,700
11 screens
US$52,556 / US$4,016,706
24 screens
9 (3) Seventh Son (PG13)
US$33,960 / US$1,441,951
30 screens
10 (6) Bring Back the Dead 招魂 (PG13)
US$33,410 / US$267,521
22 screens
Other debuts:
Whiplash (NC16 Edited)
US$26,969 / US$28,639
7 screens
Bhopal: A Prayer for Rain (PG)
N.A.
1 screen
Legend:
This Week / Last Week / Title / Rating
Weekend Gross / Total Gross
Source: Box Office Mojo
No comments:
Post a Comment